Molecular Interactions


Protein-Protein Interaction Assay
Protein-protein interactions (PPIs) as putative therapeutic targets for new treatments is challenging but gaining ground in the drug discovery industry for its significant progress in many diseases including cancer, cardiovascular disease and so on. Genus Biotech has extensive experiences and advanced approaches on protein-protein interaction study. We could help you map the interacting network for your target proteins, validate the binding partners, and also design, discover and decipher the novel drugs.

In Genus Biotech, the approaches for PPI detection are mainly classified into three types, in vivo, in vitro, and in silico methods. In vivo techniques include yeast two-hybrid system (Y2H), mammalian two-hybrid system (M2H), bacterial two-hybrid system (B2H) and reverse two-hybrid system (rY2H). For in vitro way, co-immunoprecipitation (co-IP), pull-down assay, protein-fragment complementation assay (PCA) and phage display.

Genus Biotech has long-devoted in providing bio-molecular interaction analysis solutions.
From experiment design to data analysis, we offer one-stop and step-to-step custom services to facilitate your project success.



For more information:
tel +39.0824.364090
fax +39.0824.364092
email info@genusbiotech.com

▲ top page

Genus Biotech
Consorzio Sannio Tech
Via Appia s.n.c. 82030 Apollosa (BN)
Italy

phone +39.0824.364090
fax +39.0824.364092
email info@genusbiotech.com







powered by
emisferodestro.it